Nuvasive Inc

NUVA's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

NUVA Growth rates comparisons

Looking into Nuvasive Inc growth rates, revenue grew by 2.36 % in the second quarter of 2023 from the same quarter a year ago. Ranking at No. 1788

Medical Equipment & Supplies industry recorded growth of revenues by 4.82 %

Nuvasive Inc realized net income compared to net loss a year ago in second quarter of 2023

• More on NUVA's Growth

NUVA's Valuation comparisons

Nuvasive Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Nuvasive Inc PEG ratio is at -0.55 Nuvasive Inc realized cash reduction of $ -2.75 per share in trailing twelve-month period.

Company

86.2

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 1.72.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.04.

• More on NUVA's Valuation

Total Debt (Millions $)	796
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	408,742
Net Income/Employee (TTM) $	9,483
Receivable Turnover (TTM)	4.89
Tangible Book Value (Per Share $)	1.59

NUVA's Valuation comparisons

Nuvasive Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Nuvasive Inc PEG ratio is at -0.55 Nuvasive Inc realized cash outflow of $ -2.75per share in trailing twelve-month period.

Company

86.2

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 1.72.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.04.

Nuvasive Inc Price to Book Ratio is at 2.36 higher than Industry Avg. of -524.29, and higher than S&P 500 Avg. of 0.02

• More on NUVA's Valuation

• Market Capitalization (Millions $)	2,103
• Shares Outstanding (Millions)	53
• Employees	3,000
• Revenues (TTM) (Millions $)	1,226
• Net Income (TTM) (Millions $)	28
• Cash Flow (TTM) (Millions $)	-145
• Capital Exp. (TTM) (Millions $)	-143
• Total Debt (Millions $)	796
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	408,742
• Net Income/Employee(TTM) $	9,483
• Receivable Turnover Ratio (TTM)	4.89
• Tangible Book Value (Per Share $)	1.59

• Market Capitalization (Millions $)	2,103
• Shares Outstanding (Millions)	53
• Employees	3,000
• Revenues (TTM) (Millions $)	1,226
• Net Income (TTM) (Millions $)	28
• Cash Flow (TTM) (Millions $)	-145
• Capital Exp. (TTM) (Millions $)	-143

NUVA's Profitability Comparisons
Nuvasive Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in second quarter of 2023 to 5.65 % from 2.33 % in I. Quarter. Nuvasive Inc net profit margin of 2.32 % is currently ranking no. 58 in Medical Equipment & Supplies industry, ranking no. 173 in Healthcare sector and number 2269 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	1.25
• Total Debt to Equity (MRQ)	0.89
• Tangible Leverage Ratio (MRQ)	12.2
• Asset Turnover Ratio (TTM)	0.57
• Inventory Turnover Ratio (TTM)	1.01

NUVA's Profitability Comparisons

Nuvasive Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in second quarter of 2023 to 5.65 % from 2.33 % in I. Quarter.

Nuvasive Inc net profit margin of 2.32 % is currently ranking no. 58 in Medical Equipment & Supplies industry, ranking no. 173 in Healthcare sector and number 2269 in S&P 500.

• More on NUVA's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.